Imaging Agent

Known as: Image Enhancement Agent 
A compound that enables or improves the visualization of body structures or functions for medical imaging.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1972-2018
05010015019722018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.
OBJECTIVE We wished to develop a highly selective positron emission tomography (PET) imaging agent targeting PHF-tau in human… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.
OBJECTIVE To determine whether preclinical Alzheimer disease (AD), as detected by the amyloid-imaging agent Pittsburgh Compound B… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo.
BACKGROUND Arterial calcification is associated with cardiovascular events; however, mechanisms of calcification in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2006
Highly Cited
2006
An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles.
Nanomaterials have become increasingly important in the development of new molecular probes for in vivo imaging, both… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques.
BACKGROUND Molecular imaging of thrombus within fissures of vulnerable atherosclerotic plaques requires sensitive detection of a… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.
UNLABELLED An ideal hypoxia imaging agent should have high membrane permeability for easy access to intracellular mitochondria… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
The multidrug-resistant P-glycoprotein (Pgp), a M(r) 170,000 plasma membrane protein encoded by the mammalian multidrug… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent.
A novel 99mTc complex (1,2-bis[bis(2-ethoxyethyl)phosphino] ethane, 99mTc-tetrofosmin) has been developed to replace 201Tl in… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.
While 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) is a useful tumor imaging agent, its intratumoral distribution has not been… (More)
Is this relevant?
Highly Cited
1983
Highly Cited
1983
The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.
The scintigraphic distribution of m-[131I]iodobenzylguanidine (I-131 MIBG), an adrenal medullary imaging agent, was studied to… (More)
Is this relevant?